One Eleven Interactive, Inc

Innovative marketing programs for the pharmaceutical industry

One Eleven Interactive, Inc Introduction Why do pharmaceutical companies love Donald Trump?

Why do pharmaceutical companies love Donald Trump?



Pharmaceutical companies love President Donald Trump, according to a new survey.

The pharmaceutical industry’s CEO has become a regular fixture on Fox News, MSNBC and on Twitter, and its CEO of an American drug company has a daily column on The Wall Street Journal.

But as pharmaceuticals companies scramble to keep up with new drugs and the opioid epidemic that’s ravaged their businesses, some are questioning whether they’re being too generous to the president and the pharmaceutical industry.

The drug industry’s chief lobbyist for President Donald J. Trump, Joe Trippi, told reporters in an interview that he’s worried that the Trump administration is doing too little to combat the opioid crisis.

“I think there’s a real concern that we’re just getting caught up in a Catch-22,” Trippid said.

“The president has to do more to tackle this problem than he has to, because the problem that he and the White House are dealing with right now is an opioid crisis.”

The Pharmaceutical Research and Manufacturers of America, the trade group for pharmaceutical companies, has sent a letter to Trump and other lawmakers asking them to increase federal spending on research to treat and prevent the opioid abuse crisis.

Trump has already announced plans to slash funding for research on the opioid.

Tripp said that Trump and pharmaceutical companies need to do a better job of communicating with lawmakers about their goals and priorities.

“They’ve got to be able to share their goals, and the way they’re communicating to the American people is, ‘We’re doing what we need to be doing,’ and we’re all on the same page, but they’re not communicating the goals,” Trippy said.

Drug companies are also struggling with a growing demand for pain medication.

The Centers for Disease Control and Prevention (CDC) reports that more than 2.2 million Americans were hospitalized for prescription opioid abuse in 2015.

The number of people in treatment for prescription pain medication rose to nearly 7.7 million in 2016, up from 5.4 million in 2015, according a CNN analysis.

As the number of prescriptions for opioid pain medications rises, so does the number seeking help for the condition, according the CDC.

The CDC reports that the number and number of Americans in treatment is at an all-time high.

The percentage of Americans who have had a prescription for an opioid has increased from 23% in 2013 to 34% in 2015 and 41% in 2016.

But the number receiving care for an addiction to pain medication has declined from 16% in 2012 to 9% in 2017, according CDC data.

Trump’s opioid plan calls for a $4 billion increase in the federal budget for addiction treatment, but the administration says that’s too low.

Trippy told CNN that the drug companies have been working for years to push for more money for treatment.

“This administration has been talking about these opioid addiction issues for years, and they’re going to do it, but we have to be willing to be open to it,” Tripps said.

President Donald Trumps plan to address the opioid problem has met with resistance from some in Congress, who want more money to be spent on treatment.

The opioid crisis is so bad that Trump has promised to increase funding for addiction prevention and treatment programs, but Tripp was adamant that Congress must pass a budget that invests in those programs.

“What I know, and what I’ve said publicly and privately to the pharmaceutical companies is, we’re going back to the old days,” Trips said.

TopBack to Top